Tumor Patients
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Single-arm, Multi-center, Phase II Exploratory Clinical Study to Evaluate the Efficacy and Safety of Trilaciclib in Preventing Myelosuppression Caused by Topoisomerase I Inhibitor Type ADC Drugs (NCT07736001) | Tianjin Medical University Cancer Institute and Hospital | 2026-07-01 |
Track Tumor Patients automatically
Every clearance here is in the API, with alerts when new ones post.